VERAPTUS® HER2 Receptor Targeting Aptamer



VERAPTUS® aptamers were selected against HER2 positive breast cancer cell lines. Validating experiments show the VERAPTUS® aptamer binds to the HER2 receptor. HER2 is a clinically relevant marker for diagnostic and therapeutic applications for certain types of breast cancer.

Purification: >1 mg of 50-80 base pair desalted DNA


There are no reviews yet.

Be the first to review “VERAPTUS® HER2 Receptor Targeting Aptamer”

Your email address will not be published. Required fields are marked *